AAAAAA

   
Results: 1-9 |
Results: 9
Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols
Authors: Atra, A Gerrard, M Hobson, R Imeson, JD Hann, IM Pinkerton, CR
Citation: A. Atra et al., Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols, BR J HAEM, 112(4), 2001, pp. 965-968
Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission - Response
Authors: Vaidya, S Atra, A Meller, S
Citation: S. Vaidya et al., Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission - Response, BONE MAR TR, 26(10), 2000, pp. 1136-1137
Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-up
Authors: Vaidya, SJ Atra, A Bahl, S Pinkerton, CR Calvagna, V Horton, C Milan, S Shepherd, V Brain, C Treleaven, J Powles, R Tait, D Meller, ST
Citation: Sj. Vaidya et al., Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-up, BONE MAR TR, 25(6), 2000, pp. 599-603
Melphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years
Authors: Kulkarni, S Powles, R Treleaven, J Singhal, S Horton, C Sirohi, B Bhagawati, N Tait, D Saso, R Killick, S Pinkerton, R Atra, A Meller, S Mehta, J
Citation: S. Kulkarni et al., Melphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years, BONE MAR TR, 25(4), 2000, pp. 365-370
Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol
Authors: Atra, A Imeson, JD Hobson, R Gerrard, M Hann, IM Eden, OB Carter, RL Pinkerton, CR
Citation: A. Atra et al., Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol, BR J CANC, 82(8), 2000, pp. 1396-1402
Acute erythroid leukemia (M6): Outcome of bone marrow transplantation
Authors: Killick, S Matutes, E Powles, RL Min, T Treleaven, JG Rege, KP Atra, A Catovsky, D
Citation: S. Killick et al., Acute erythroid leukemia (M6): Outcome of bone marrow transplantation, LEUK LYMPH, 35(1-2), 1999, pp. 99
Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma
Authors: Shankar, AG Pinkerton, CR Atra, A Ashley, S Lewis, I Spooner, D Cannon, S Grimer, R Cotterill, SJ Craft, AW
Citation: Ag. Shankar et al., Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma, EUR J CANC, 35(12), 1999, pp. 1698-1704
Outcome of biphenotypic acute leukemia
Authors: Killick, S Matutes, E Powles, RL Hamblin, M Swansbury, J Treleaven, JG Zomas, A Atra, A Catovsky, D
Citation: S. Killick et al., Outcome of biphenotypic acute leukemia, HAEMATOLOG, 84(8), 1999, pp. 699-706
A limited role for VEEP (vincristine, etoposide, epirubicin, prednisolone)chemotherapy in childhood Hodgkin's disease
Authors: Shankar, AG Ashley, S Atra, A Kingston, JE Mott, M Pinkerton, CR
Citation: Ag. Shankar et al., A limited role for VEEP (vincristine, etoposide, epirubicin, prednisolone)chemotherapy in childhood Hodgkin's disease, EUR J CANC, 34(13), 1998, pp. 2058-2063
Risultati: 1-9 |